Evaluation of Pre-hospital use of a Valsalva Assist Device (VAD) in the Emergency treatment of supraventricular tachycardia (SVT). A definitive stepped-wedge cluster randomised controlled trial [EVADE SVT]

South Western Ambulance Service NHS Foundation Trust0 个研究点目标入组 865 人开始时间: 2022年3月24日最近更新: 2024年7月22日

适应症

试验速览

2023 Protocol article in https://doi.org/10.1136/bmjopen-2023-073315 (added 09/06/2023)

•1. Adult patients (above 17 years)
•2. Record of a Valsalva manoeuvre for presumed supraventricular tachycardia having been delivered by an ambulance clinician asigned to an ambulance station cluster.

•1. Subsequent withdrawal of patient consent to use data
•2. Data from participants who are prisoners at the time of treatment
•3. Patients with permanent lack of capacity as recorded by the treating clinician
•4. Patients solely treated by a SWASFT resource not from one of the included ambulance station clusters e.g. Air Ambulance, Hazardous Area Response Team, Tiverton Minor Injuries Unit, British Association for Immediate Care (BASICS) Doctor
•5. Data from patients previously included in the study will be excluded from the primary analysis but will be used in other secondary analyses
•6. Patients who have previously registered with the National Data Opt-out service

发起方